MetroBoston Clinical Partners, LLC

Brighton, Massachusetts 02135-3511

1 studies enrolling now · 8 studies all time

What they study most

Alopecia Areata, Atopic Dermatitis, Dermatitis, Atopic, EPP, Erythropoietic Protoporphyria (EPP), X-Linked Protoporphyria (XLP), XLP

Studies at this site

• Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) — Recruiting now
• INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP — Completed
• Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Completed
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria — Completed
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria — Completed
• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) — Completed
• Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy — Completed
• A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis — Completed